Graham (NYSE:GHM – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Tuesday.
Graham Price Performance
NYSE GHM traded up $0.09 during trading on Tuesday, reaching $29.37. The company’s stock had a trading volume of 88,610 shares, compared to its average volume of 77,113. The firm has a fifty day moving average of $27.26 and a 200 day moving average of $22.04. Graham has a one year low of $10.77 and a one year high of $34.72. The stock has a market capitalization of $318.08 million, a PE ratio of 112.97 and a beta of 0.58.
Graham (NYSE:GHM – Get Free Report) last posted its quarterly earnings data on Monday, February 5th. The industrial products company reported $0.02 earnings per share for the quarter, topping the consensus estimate of ($0.04) by $0.06. Graham had a net margin of 1.52% and a return on equity of 2.73%. The company had revenue of $43.82 million for the quarter, compared to analysts’ expectations of $37.88 million. During the same period in the prior year, the business earned $0.03 earnings per share.
Institutional Trading of Graham
Graham Company Profile
Graham Corporation, together with its subsidiaries, designs and manufactures fluid, power, heat transfer, and vacuum equipment for chemical and petrochemical processing, defense, space, petroleum refining, cryogenic, energy, and other industries. It offers power plant systems, including ejectors and surface condensers; torpedo ejection, propulsion, and power systems, such as turbines, alternators, regulators, pumps, and blowers; and thermal management systems comprising pumps, blowers, and drive electronics for defense sector.
See Also
- Five stocks we like better than Graham
- How to Effectively Use the MarketBeat Ratings Screener
- Garmin Navigates to New Highs Driven By Wearables Trend
- Canadian Penny Stocks: Can They Make You Rich?
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- How to Use the MarketBeat Dividend Calculator
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Graham Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Graham and related companies with MarketBeat.com's FREE daily email newsletter.